PT  - JOURNAL ARTICLE
AU  - Guinee, Emily P.
AU  - Raza, Haniya
AU  - Ballard, Elizabeth D.
AU  - Shaw, Jacob S.
AU  - Liang, C. Jason
AU  - Sneller, Michael C.
AU  - Chung, Joyce Y.
TI  - Pandemic-Related Post-traumatic Stress Symptomatology in COVID-19 Patients with and without Post-COVID Conditions
AID  - 10.1101/2024.01.21.24301574
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.01.21.24301574
4099  - http://medrxiv.org/content/early/2024/01/22/2024.01.21.24301574.short
4100  - http://medrxiv.org/content/early/2024/01/22/2024.01.21.24301574.full
AB  - Trauma and stressor-related symptoms have been frequently reported during the COVID-19 pandemic. Few studies compare post-traumatic stress symptoms (PTSS) between patients and non-infected controls. Using data from an ongoing natural history study of COVID-19, this study compared PTSS between patients infected with SARS-CoV-2 during the first year of the pandemic and controls. Within the COVID-19 patient cohort, we also compared PTSS between patients with and without post-COVID conditions, also known as post-acute sequelae of SARS-CoV-2 infection (PASC). This study also examined the association of PTSS with trait resilience and prior trauma exposure. PTSS were assessed using the Impact of Event Scaled-Revised (IES-R), which has a validated probable PTSD cutoff (score ≥33). The results showed that patients (n=131) reported significantly higher IES-R scores than controls (n=82) and had significantly higher odds of having scores indicative of PTSD [AOR: 4.17 p: 0.029]. IES-R scores among PASC patients (n=68) were significantly elevated compared to patients without PASC (n=63) and PASC patients did not have higher odds for probable PTSD [AOR: 2.60; p: 0.14]. Trait resilience was associated with lower PTSS. These findings help characterize the mental health impact of the COVID-19 illness experience and highlight elevated PTSS in patients with persistent post-COVID conditions.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://clinicaltrials.gov/study/NCT04411147?lat=39.0019296&lng=-77.1044561&locStr=NIH%20Clinical%20Center,%20Center%20Drive,%20Bethesda,%20MD&distance=50&cond=covid%2019&term=sneller%20niaid&rank=1 Funding StatementThis study was funded by: This work was supported by the Intramural Research Program of the National Institute of Mental Health [annual report number ZIAMH002922] and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases and in part by federal funds from the National Cancer Institute, National Institutes of Health [contract no. 75N91019D00024].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the National Institutes of Health Clinical Center gave approval of this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesResearch data are not shared.